Dr. Bin Sing Teh, MD

Dr. Teh practices at Houston Methodist Hospital in Houston, Texas, part of Houston Methodist.

Dr. Teh's NPI, 1164414439, was assigned on August 22, 2005. Dr. Teh graduated from The University of Queensland Medical School in 1990. Dr. Teh holds Texas license K7918.

Dr. Teh's primary practice is Houston Methodist Hospital, at 6565 Fannin, Houston, TX 77030 in Harris County. The practice phone is (713) 790-2221.

Dr. Teh's primary practice is Houston Methodist Hospital in Houston, Texas, part of Houston Methodist. Dr. Teh is also affiliated with Houston Methodist West Hospital. The medical group on file is Houston Methodist Specialty Physician Group. Dmand AI also links Dr. Teh to 3 more hospitals, 2 medical groups and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Teh practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Teh's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Teh is board certified in radiation oncology by the American Board of Radiology. Dr. Teh is licensed in Texas.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation and head & neck cancer radiation among the conditions Dr. Teh treats.

CMS data shows 4,341 Medicare services from Dr. Teh across 21 procedure codes in 2024, for 298 Medicare patients. Medicare paid $356,718 for them.

CMS counts 298 Medicare patients who saw Dr. Teh in 2024. The largest group is 65 to 74, with 158 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Teh's median patient age at 73, with 63% women.

In 2024, Dr. Teh wrote 206 Medicare Part D claims for 123 patients. 88% of them were for generic drugs. CMS names the drug for 142 of them, across 5 drugs with 11 or more claims each, at $1,969 in total drug cost. In 2023, CMS named 60 claims across 2 drugs.

Dr. Teh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Teh as offering telehealth.

Dmand AI links 215 papers to Dr. Teh, published from 2005 to 2025. 2019 was the busiest year, with 17. The most frequent topics are Radiosurgery, Prostatic Neoplasms and Radiotherapy Dosage. Dr. Teh has published most often in Int J Radiat Oncol Biol Phys. Dr. Teh's most frequent co-authors are Edward Brian Butler, MD, Waqar M. Haque and Andrew M. Farach, MD.

Dmand AI links Dr. Teh to 1 clinical trial. Conditions studied include Glioblastoma and Astrocytoma.

CMS Open Payments shows 36 general payments to Dr. Teh from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 67% of the total. Carl Zeiss Meditec, Inc. paid the most, $1,320.

Dmand AI lists 1 award for Dr. Teh, most recently CMS Stage 1 EHR in 2013.

Dr. Teh graduated from The University of Queensland Medical School in 1990.

Dr. Teh is in network with 15 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.